Portfolio (Quarterly)
Guide ↗
Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CYTK | CYTOKINETICS INC | Healthcare | 3,333,333.0 | $219.7M | 2.16% | NEW | — | $65.91 | +18.5% |
| 2 | — | DAMORA THERAPEUTICS INC | — | 3,783,000.0 | $98.0M | 0.96% | NEW | — | $25.90 | — |
| 3 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 5,000,000.0 | $94.5M | 0.93% | NEW | — | $18.90 | +29.3% |
| 4 | — | AVALO THERAPEUTICS | — | 1,410,000.0 | $21.1M | 0.21% | NEW | — | $14.93 | — |
| 5 | UTHR CALL | UNITED THERAPEUTICS CORP | Healthcare | 380,000.0 | $10.3M | 0.10% | NEW | — | $27.09 | +1935.3% |
| 6 | CELC CALL | CELCUITY INC | Healthcare | 200,000.0 | $3.0M | 0.03% | NEW | — | $15.25 | +477.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%